Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Matino

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
TH Open : Companion Journal to Thrombosis and Haemostasis|July 8, 2021
Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand DiseaseMichelle Sholzberg, Kate Khair, Hassan Yaish, et al.
Research and Practice in Thrombosis and Haemostasis|April 7, 2022
Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real-world, multicenter, retrospective studyDavide Matino, Alfonso Iorio, Arun Keepanasseril, et al.
Therapeutic Advances in Hematology|April 8, 2022
International consensus recommendations on the management of people with haemophilia BDaniel P Hart, Davide Matino, Jan Astermark, et al.
The New England Journal of Medicine|January 31, 2023
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia AAnnette von Drygalski, Pratima Chowdary, Roshni Kulkarni, et al.
Frontiers in Immunology|April 29, 2017
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune DiabetesGiada Mondanelli, Elisa Albini, Maria T Pallotta, et al.
Research and Practice in Thrombosis and Haemostasis|January 16, 2026
Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective studyOmotola O Olasupo, Emma Iserman, Arun Keepanasseril, et al.
Human Vaccines & Immunotherapeutics|June 19, 2019
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccineSonia Bianchini, Ciriana Orabona, Barbara Camilloni, et al.
European Journal of Pharmacology|June 11, 2018
S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cellsRita Romani, Giorgia Manni, Chiara Donati, et al.
Journal of Thrombosis and Haemostasis : JTH|October 19, 2025
Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trialKaan Kavakli, Adam Cuker, Laurent Frenzel, et al.
Journal of Cellular and Molecular Medicine|March 19, 2015
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1Rita Romani, Irene Pirisinu, Mario Calvitti, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
TH Open : Companion Journal to Thrombosis and Haemostasis|July 8, 2021
Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand DiseaseMichelle Sholzberg, Kate Khair, Hassan Yaish, et al.
Research and Practice in Thrombosis and Haemostasis|April 7, 2022
Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real-world, multicenter, retrospective studyDavide Matino, Alfonso Iorio, Arun Keepanasseril, et al.
Therapeutic Advances in Hematology|April 8, 2022
International consensus recommendations on the management of people with haemophilia BDaniel P Hart, Davide Matino, Jan Astermark, et al.
The New England Journal of Medicine|January 31, 2023
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia AAnnette von Drygalski, Pratima Chowdary, Roshni Kulkarni, et al.
Frontiers in Immunology|April 29, 2017
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune DiabetesGiada Mondanelli, Elisa Albini, Maria T Pallotta, et al.
Research and Practice in Thrombosis and Haemostasis|January 16, 2026
Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective studyOmotola O Olasupo, Emma Iserman, Arun Keepanasseril, et al.
Human Vaccines & Immunotherapeutics|June 19, 2019
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccineSonia Bianchini, Ciriana Orabona, Barbara Camilloni, et al.
European Journal of Pharmacology|June 11, 2018
S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cellsRita Romani, Giorgia Manni, Chiara Donati, et al.
Journal of Thrombosis and Haemostasis : JTH|October 19, 2025
Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trialKaan Kavakli, Adam Cuker, Laurent Frenzel, et al.
Journal of Cellular and Molecular Medicine|March 19, 2015
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1Rita Romani, Irene Pirisinu, Mario Calvitti, et al.
Pageof 7